 | • レポートコード：MRC22NVL19168 • 出版社/出版日：LP Information / 2022年10月 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥541,680 (USD3,660) | ▷ お問い合わせ |
| Corporate User | ￥1,083,360 (USD7,320) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 世界経済が回復するにつれて、2021年のヨウ素含有造影剤の成長は前年から大幅に変化します。LP Information社（米国）の最新の調査によると、世界のヨウ素含有造影剤市場規模は、2021年の000ドルから2022年には000ドルに達し、2021年～2022年間に000%の成長が予想されます。2028年には世界のヨウ素含有造影剤市場規模が000ドルまで成長し、調査期間中に000%の年平均成長率を記録すると予想されます。 米国のヨウ素含有造影剤市場は2021年に000ドルの市場規模が見込まれ、調査期間中は約000%の年平均成長率で成長すると予測されます。中国は世界のヨウ素含有造影剤市場の000%のシェアを占め、2028年までに000ドルに達すると展望されます。欧州のヨウ素含有造影剤の状況については、ドイツが2028年までに000ドルに達し、調査期間にわたって年平均成長率が000%になると予測されます。アジア地域では、日本と韓国の成長率が、今後5年間でそれぞれ000%と000%になると展望されます。 世界の主要なヨウ素含有造影剤プレーヤーとして、GE Healthcare、 Bayer、 Bracco Imaging、 Guerbet Group、 Hengrui Medicine、 Lantheus、 Sanochemia、 Tyco Healthcare、 Imax、 Takeda、 Fuji Pharma、 Towaseiyaku、 Hikari Pharmaceutical、 Consentis Diagnostics GmbH、 T2Pharma、 YRPG、 BeiLu Pharma、 Grupo Juste、 Daiichi Sankyoなどをカバーしています。売上の面では、世界のトップ2社が2021年に約000%市場シェアを占めています。 当レポートでは、製品タイプ、用途（アプリケーション）、主要メーカー、主要地域および国ごとのヨウ素含有造影剤市場の包括的な概要、市場シェア、および成長機会を掲載します。 タイプ別のセグメンテーション：2017年～2022年までの内訳データと2028年まで予測データ イオヘキソール、ヨウジキサノール、イオパミドール、イオベソル、その他 用途（アプリケーション）別のセグメンテーション：2017年～2022年までの内訳データと2028年まで予測データ 病院、クリニック、その他 当レポートは次の地域と国の市場規模データを掲載します。 南北アメリカ（米国、カナダ、メキシコ、ブラジル） アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア） 欧州（ドイツ、フランス、イギリス、イタリア、ロシア） 中東/アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国） ********* 目次 ********* レポートの範囲 ・市場の紹介 ・分析対象期間 ・調査の目的 ・調査手法 ・調査プロセスおよびデータソース ・経済指標 ・通貨 エグゼクティブサマリー ・世界市場の概要：ヨウ素含有造影剤の年間販売量2017-2028、地域別現状・将来分析 ・ヨウ素含有造影剤のタイプ別セグメント：イオヘキソール、ヨウジキサノール、イオパミドール、イオベソル、その他 ・ヨウ素含有造影剤のタイプ別販売量：2017-2022年の販売量、売上、市場シェア、販売価格 ・ヨウ素含有造影剤の用途別セグメント：病院、クリニック、その他 ・ヨウ素含有造影剤の用途別販売量：2017-2022年の販売量、売上、市場シェア、販売価格 企業別世界のヨウ素含有造影剤市場 ・企業別のグローバルヨウ素含有造影剤市場データ：2020-2022年の年間販売量、市場シェア ・企業別のヨウ素含有造影剤の年間売上：2020-2022年の売上、市場シェア ・企業別のヨウ素含有造影剤販売価格 ・主要企業のヨウ素含有造影剤生産地域、販売地域、製品タイプ ・市場集中度分析 ・新製品および潜在的な参加者 ・合併と買収、拡大 ヨウ素含有造影剤の地域別レビュー ・地域別のヨウ素含有造影剤市場規模2017-2022：年間販売量、売上 ・主要国別のヨウ素含有造影剤市場規模2017-2022：年間販売量、売上 ・南北アメリカのヨウ素含有造影剤販売の成長 ・アジア太平洋のヨウ素含有造影剤販売の成長 ・欧州のヨウ素含有造影剤販売の成長 ・中東・アフリカのヨウ素含有造影剤販売の成長 南北アメリカ市場 ・南北アメリカの国別のヨウ素含有造影剤販売量、売上（2017-2022） ・南北アメリカのヨウ素含有造影剤の種類別販売量 ・南北アメリカのヨウ素含有造影剤の用途別販売量 ・米国のヨウ素含有造影剤市場 ・カナダのヨウ素含有造影剤市場 ・メキシコのヨウ素含有造影剤市場 ・ブラジルのヨウ素含有造影剤市場 アジア太平洋市場 ・アジア太平洋の国別のヨウ素含有造影剤販売量、売上（2017-2022） ・アジア太平洋のヨウ素含有造影剤の種類別販売量 ・アジア太平洋のヨウ素含有造影剤の用途別販売量 ・中国市場のヨウ素含有造影剤市場 ・日本市場のヨウ素含有造影剤市場 ・韓国市場のヨウ素含有造影剤市場 ・東南アジアのヨウ素含有造影剤市場 ・インドのヨウ素含有造影剤市場 ・オーストラリアのヨウ素含有造影剤市場 ・台湾のヨウ素含有造影剤市場 欧州市場 ・欧州の国別のヨウ素含有造影剤販売量、売上（2017-2022） ・欧州のヨウ素含有造影剤の種類別販売量 ・欧州のヨウ素含有造影剤の用途別販売量 ・ドイツのヨウ素含有造影剤市場 ・フランスのヨウ素含有造影剤市場 ・イギリスのヨウ素含有造影剤市場 ・イタリアのヨウ素含有造影剤市場 ・ロシアのヨウ素含有造影剤市場 中東・アフリカ市場 ・中東・アフリカの国別のヨウ素含有造影剤販売量、売上（2017-2022） ・中東・アフリカのヨウ素含有造影剤の種類別販売量 ・中東・アフリカのヨウ素含有造影剤の用途別販売量 ・エジプトのヨウ素含有造影剤市場 ・南アフリカのヨウ素含有造影剤市場 ・イスラエルのヨウ素含有造影剤市場 ・トルコのヨウ素含有造影剤市場 ・GCC諸国のヨウ素含有造影剤市場 市場の成長要因、課題、動向 ・市場の成長要因および成長機会分析 ・市場の課題およびリスク ・市場動向 製造コスト構造分析 ・原材料とサプライヤー ・ヨウ素含有造影剤の製造コスト構造分析 ・ヨウ素含有造影剤の製造プロセス分析 ・ヨウ素含有造影剤の産業チェーン構造 マーケティング、販売業者および顧客 ・販売チャンネル：直接販売チャンネル、間接販売チャンネル ・ヨウ素含有造影剤の主要なグローバル販売業者 ・ヨウ素含有造影剤の主要なグローバル顧客 地域別のヨウ素含有造影剤市場予測レビュー ・地域別のヨウ素含有造影剤市場規模予測（2023-2028） ・南北アメリカの国別予測 ・アジア太平洋の国別予測 ・欧州の国別予測 ・ヨウ素含有造影剤のタイプ別市場規模予測 ・ヨウ素含有造影剤の用途別市場規模予測 主要企業分析 GE Healthcare、 Bayer、 Bracco Imaging、 Guerbet Group、 Hengrui Medicine、 Lantheus、 Sanochemia、 Tyco Healthcare、 Imax、 Takeda、 Fuji Pharma、 Towaseiyaku、 Hikari Pharmaceutical、 Consentis Diagnostics GmbH、 T2Pharma、 YRPG、 BeiLu Pharma、 Grupo Juste、 Daiichi Sankyo ・企業情報 ・ヨウ素含有造影剤製品 ・ヨウ素含有造影剤販売量、売上、価格、粗利益（2020-2022） ・主要ビジネス概要 ・最新動向 調査結果および結論 |
As the global economy mends, the 2021 growth of Iodine-containing Contrast Medium will have significant change from previous year. According to our (LP Information) latest study, the global Iodine-containing Contrast Medium market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Iodine-containing Contrast Medium market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.
The United States Iodine-containing Contrast Medium market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Iodine-containing Contrast Medium market, reaching US$ million by the year 2028. As for the Europe Iodine-containing Contrast Medium landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Iodine-containing Contrast Medium players cover GE Healthcare, Bayer, Bracco Imaging, and Guerbet Group, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Iodine-containing Contrast Medium market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Iohexol
Iodixanol
Iopamidol
Ioversol
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospitals
Clinics
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
GE Healthcare
Bayer
Bracco Imaging
Guerbet Group
Hengrui Medicine
Lantheus
Sanochemia
Tyco Healthcare
Imax
Takeda
Fuji Pharma
Towaseiyaku
Hikari Pharmaceutical
Consentis Diagnostics GmbH
T2Pharma
YRPG
BeiLu Pharma
Grupo Juste
Daiichi Sankyo
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Iodine-containing Contrast Medium Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Iodine-containing Contrast Medium by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Iodine-containing Contrast Medium by Country/Region, 2017, 2022 & 2028
2.2 Iodine-containing Contrast Medium Segment by Type
2.2.1 Iohexol
2.2.2 Iodixanol
2.2.3 Iopamidol
2.2.4 Ioversol
2.2.5 Others
2.3 Iodine-containing Contrast Medium Sales by Type
2.3.1 Global Iodine-containing Contrast Medium Sales Market Share by Type (2017-2022)
2.3.2 Global Iodine-containing Contrast Medium Revenue and Market Share by Type (2017-2022)
2.3.3 Global Iodine-containing Contrast Medium Sale Price by Type (2017-2022)
2.4 Iodine-containing Contrast Medium Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Iodine-containing Contrast Medium Sales by Application
2.5.1 Global Iodine-containing Contrast Medium Sale Market Share by Application (2017-2022)
2.5.2 Global Iodine-containing Contrast Medium Revenue and Market Share by Application (2017-2022)
2.5.3 Global Iodine-containing Contrast Medium Sale Price by Application (2017-2022)
3 Global Iodine-containing Contrast Medium by Company
3.1 Global Iodine-containing Contrast Medium Breakdown Data by Company
3.1.1 Global Iodine-containing Contrast Medium Annual Sales by Company (2020-2022)
3.1.2 Global Iodine-containing Contrast Medium Sales Market Share by Company (2020-2022)
3.2 Global Iodine-containing Contrast Medium Annual Revenue by Company (2020-2022)
3.2.1 Global Iodine-containing Contrast Medium Revenue by Company (2020-2022)
3.2.2 Global Iodine-containing Contrast Medium Revenue Market Share by Company (2020-2022)
3.3 Global Iodine-containing Contrast Medium Sale Price by Company
3.4 Key Manufacturers Iodine-containing Contrast Medium Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Iodine-containing Contrast Medium Product Location Distribution
3.4.2 Players Iodine-containing Contrast Medium Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Iodine-containing Contrast Medium by Geographic Region
4.1 World Historic Iodine-containing Contrast Medium Market Size by Geographic Region (2017-2022)
4.1.1 Global Iodine-containing Contrast Medium Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Iodine-containing Contrast Medium Annual Revenue by Geographic Region
4.2 World Historic Iodine-containing Contrast Medium Market Size by Country/Region (2017-2022)
4.2.1 Global Iodine-containing Contrast Medium Annual Sales by Country/Region (2017-2022)
4.2.2 Global Iodine-containing Contrast Medium Annual Revenue by Country/Region
4.3 Americas Iodine-containing Contrast Medium Sales Growth
4.4 APAC Iodine-containing Contrast Medium Sales Growth
4.5 Europe Iodine-containing Contrast Medium Sales Growth
4.6 Middle East & Africa Iodine-containing Contrast Medium Sales Growth
5 Americas
5.1 Americas Iodine-containing Contrast Medium Sales by Country
5.1.1 Americas Iodine-containing Contrast Medium Sales by Country (2017-2022)
5.1.2 Americas Iodine-containing Contrast Medium Revenue by Country (2017-2022)
5.2 Americas Iodine-containing Contrast Medium Sales by Type
5.3 Americas Iodine-containing Contrast Medium Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Iodine-containing Contrast Medium Sales by Region
6.1.1 APAC Iodine-containing Contrast Medium Sales by Region (2017-2022)
6.1.2 APAC Iodine-containing Contrast Medium Revenue by Region (2017-2022)
6.2 APAC Iodine-containing Contrast Medium Sales by Type
6.3 APAC Iodine-containing Contrast Medium Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Iodine-containing Contrast Medium by Country
7.1.1 Europe Iodine-containing Contrast Medium Sales by Country (2017-2022)
7.1.2 Europe Iodine-containing Contrast Medium Revenue by Country (2017-2022)
7.2 Europe Iodine-containing Contrast Medium Sales by Type
7.3 Europe Iodine-containing Contrast Medium Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Iodine-containing Contrast Medium by Country
8.1.1 Middle East & Africa Iodine-containing Contrast Medium Sales by Country (2017-2022)
8.1.2 Middle East & Africa Iodine-containing Contrast Medium Revenue by Country (2017-2022)
8.2 Middle East & Africa Iodine-containing Contrast Medium Sales by Type
8.3 Middle East & Africa Iodine-containing Contrast Medium Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Iodine-containing Contrast Medium
10.3 Manufacturing Process Analysis of Iodine-containing Contrast Medium
10.4 Industry Chain Structure of Iodine-containing Contrast Medium
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Iodine-containing Contrast Medium Distributors
11.3 Iodine-containing Contrast Medium Customer
12 World Forecast Review for Iodine-containing Contrast Medium by Geographic Region
12.1 Global Iodine-containing Contrast Medium Market Size Forecast by Region
12.1.1 Global Iodine-containing Contrast Medium Forecast by Region (2023-2028)
12.1.2 Global Iodine-containing Contrast Medium Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Iodine-containing Contrast Medium Forecast by Type
12.7 Global Iodine-containing Contrast Medium Forecast by Application
13 Key Players Analysis
13.1 GE Healthcare
13.1.1 GE Healthcare Company Information
13.1.2 GE Healthcare Iodine-containing Contrast Medium Product Offered
13.1.3 GE Healthcare Iodine-containing Contrast Medium Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 GE Healthcare Main Business Overview
13.1.5 GE Healthcare Latest Developments
13.2 Bayer
13.2.1 Bayer Company Information
13.2.2 Bayer Iodine-containing Contrast Medium Product Offered
13.2.3 Bayer Iodine-containing Contrast Medium Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Bayer Main Business Overview
13.2.5 Bayer Latest Developments
13.3 Bracco Imaging
13.3.1 Bracco Imaging Company Information
13.3.2 Bracco Imaging Iodine-containing Contrast Medium Product Offered
13.3.3 Bracco Imaging Iodine-containing Contrast Medium Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Bracco Imaging Main Business Overview
13.3.5 Bracco Imaging Latest Developments
13.4 Guerbet Group
13.4.1 Guerbet Group Company Information
13.4.2 Guerbet Group Iodine-containing Contrast Medium Product Offered
13.4.3 Guerbet Group Iodine-containing Contrast Medium Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Guerbet Group Main Business Overview
13.4.5 Guerbet Group Latest Developments
13.5 Hengrui Medicine
13.5.1 Hengrui Medicine Company Information
13.5.2 Hengrui Medicine Iodine-containing Contrast Medium Product Offered
13.5.3 Hengrui Medicine Iodine-containing Contrast Medium Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Hengrui Medicine Main Business Overview
13.5.5 Hengrui Medicine Latest Developments
13.6 Lantheus
13.6.1 Lantheus Company Information
13.6.2 Lantheus Iodine-containing Contrast Medium Product Offered
13.6.3 Lantheus Iodine-containing Contrast Medium Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Lantheus Main Business Overview
13.6.5 Lantheus Latest Developments
13.7 Sanochemia
13.7.1 Sanochemia Company Information
13.7.2 Sanochemia Iodine-containing Contrast Medium Product Offered
13.7.3 Sanochemia Iodine-containing Contrast Medium Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Sanochemia Main Business Overview
13.7.5 Sanochemia Latest Developments
13.8 Tyco Healthcare
13.8.1 Tyco Healthcare Company Information
13.8.2 Tyco Healthcare Iodine-containing Contrast Medium Product Offered
13.8.3 Tyco Healthcare Iodine-containing Contrast Medium Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Tyco Healthcare Main Business Overview
13.8.5 Tyco Healthcare Latest Developments
13.9 Imax
13.9.1 Imax Company Information
13.9.2 Imax Iodine-containing Contrast Medium Product Offered
13.9.3 Imax Iodine-containing Contrast Medium Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Imax Main Business Overview
13.9.5 Imax Latest Developments
13.10 Takeda
13.10.1 Takeda Company Information
13.10.2 Takeda Iodine-containing Contrast Medium Product Offered
13.10.3 Takeda Iodine-containing Contrast Medium Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Takeda Main Business Overview
13.10.5 Takeda Latest Developments
13.11 Fuji Pharma
13.11.1 Fuji Pharma Company Information
13.11.2 Fuji Pharma Iodine-containing Contrast Medium Product Offered
13.11.3 Fuji Pharma Iodine-containing Contrast Medium Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Fuji Pharma Main Business Overview
13.11.5 Fuji Pharma Latest Developments
13.12 Towaseiyaku
13.12.1 Towaseiyaku Company Information
13.12.2 Towaseiyaku Iodine-containing Contrast Medium Product Offered
13.12.3 Towaseiyaku Iodine-containing Contrast Medium Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Towaseiyaku Main Business Overview
13.12.5 Towaseiyaku Latest Developments
13.13 Hikari Pharmaceutical
13.13.1 Hikari Pharmaceutical Company Information
13.13.2 Hikari Pharmaceutical Iodine-containing Contrast Medium Product Offered
13.13.3 Hikari Pharmaceutical Iodine-containing Contrast Medium Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Hikari Pharmaceutical Main Business Overview
13.13.5 Hikari Pharmaceutical Latest Developments
13.14 Consentis Diagnostics GmbH
13.14.1 Consentis Diagnostics GmbH Company Information
13.14.2 Consentis Diagnostics GmbH Iodine-containing Contrast Medium Product Offered
13.14.3 Consentis Diagnostics GmbH Iodine-containing Contrast Medium Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Consentis Diagnostics GmbH Main Business Overview
13.14.5 Consentis Diagnostics GmbH Latest Developments
13.15 T2Pharma
13.15.1 T2Pharma Company Information
13.15.2 T2Pharma Iodine-containing Contrast Medium Product Offered
13.15.3 T2Pharma Iodine-containing Contrast Medium Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 T2Pharma Main Business Overview
13.15.5 T2Pharma Latest Developments
13.16 YRPG
13.16.1 YRPG Company Information
13.16.2 YRPG Iodine-containing Contrast Medium Product Offered
13.16.3 YRPG Iodine-containing Contrast Medium Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 YRPG Main Business Overview
13.16.5 YRPG Latest Developments
13.17 BeiLu Pharma
13.17.1 BeiLu Pharma Company Information
13.17.2 BeiLu Pharma Iodine-containing Contrast Medium Product Offered
13.17.3 BeiLu Pharma Iodine-containing Contrast Medium Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 BeiLu Pharma Main Business Overview
13.17.5 BeiLu Pharma Latest Developments
13.18 Grupo Juste
13.18.1 Grupo Juste Company Information
13.18.2 Grupo Juste Iodine-containing Contrast Medium Product Offered
13.18.3 Grupo Juste Iodine-containing Contrast Medium Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Grupo Juste Main Business Overview
13.18.5 Grupo Juste Latest Developments
13.19 Daiichi Sankyo
13.19.1 Daiichi Sankyo Company Information
13.19.2 Daiichi Sankyo Iodine-containing Contrast Medium Product Offered
13.19.3 Daiichi Sankyo Iodine-containing Contrast Medium Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 Daiichi Sankyo Main Business Overview
13.19.5 Daiichi Sankyo Latest Developments
14 Research Findings and Conclusion